Wow what exciting news from Moderna ! So happy to hear that science is evolving and Moderna is one of the key spearheads in the industry.
Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...

